Kane Biotech Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was CAD 0.839579 million compared to CAD 0.278741 million a year ago. Net loss was CAD 0.899991 million compared to CAD 0.904487 million a year ago.
For the six months, sales was CAD 1.41 million compared to CAD 0.65478 million a year ago. Net loss was CAD 2.01 million compared to CAD 1.81 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.02 a year ago.